The increased incidence of chronic conditions among American children predicts serious strains on health care and social welfare systems in the future, caution investigators from Massachusetts General Hospital and Harvard School of Public Health.
Obese diabetes patients may lose weight effectively and decrease their use of glucose-controlling medications with a plate and cereal bowl with markers for proper portion sizes, revealed in a new study.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced study results comparing treatment with BYETTA(R) (exenatide) injection with insulin glargine in people with type 2 diabetes.
A plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications, according to a report in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Novo Nordisk (NYSE:NVO) has announced results of a new study that further demonstrated the safety and efficacy of insulin Levemir? (insulin detemir [rDNA origin] injection).
Galvus (vildagliptin) by Novartis AG (NYSE: NVS), a new once-daily oral treatment for type 2 diabetes submitted for approval in the US and Europe, has been shown in new clinical data to deliver consistent and robust blood sugar reductions in patients with this progressive disease estimated to affect about 246 million people worldwide.
Keeping cool on hot, humid summer days is good advice for more reasons than sheer comfort. It’s vital for good health – even staying alive. That’s the message from the Pennsylvania Medical Society, warning young and old alike that heat stroke is a deadly illness to be avoided at all costs – even if it means sacrificing a day at the beach.
A new analysis of data from three large national databases finds that in the 29 years between 1971 and 2000, the death rate of men with diabetes has dropped significantly, in line with the overall decline of the death rate for all Americans. But the death rate for women with diabetes did not decline at all.
A team led by Horst Kunst at the University of Mainz has found a way to bind a molecule that is typical for tumors to a carrier protein without irritating the immune system. As they report in the journal Angewandte Chemie, their method is based on an immunocompatible connection by way of a sulfur atom, namely, a thioether.
Look at the clock. In the next three minutes, 10 people in America will suffer a coronary event or stroke, and only six of them will survive. According to a recent report by the American Heart Association (AHA), coronary heart disease (CHD) affects more than 15 million Americans; over five million more are affected by stroke.